Developments in optimizing transperineal prostate biopsy.
Developments in optimizing transperineal prostate biopsy.
复制标题
DOI:
10.1097/mou.0000000000000947
复制
发表时间:
2022-01-01
影响因子:
2.5
通讯作者:
Basourakos SP
中科院分区:
文献类型:
--
作者:
Cheng E;Davuluri M;Lewicki PJ;Hu JC;Basourakos SP
Prostate biopsy is a very commonly performed office procedure leading to the diagnosis of the most prevalent solid-organ malignancy in American men. Although the transrectal (TR) technique for prostate biopsy remains the gold standard, there is increasing interest in the transperineal (TP) approach, because it offers a clean, percutaneous approach that significantly decreases the risk for infection. In this review, we discuss emerging developments in TP prostate biopsy that may optimize the way biopsies are performed in clinical practice. Similarly, to TR biopsy, the TP approach also allows for the performance of systematic and MRI-targeted biopsy cores. Because TP biopsy obviates the translocation of rectal bacteria to the prostate or bloodstream, in contrast to TR biopsy, it is feasible to forgo peri-procedural antibiotics in accordance with professional guidelines. This may attenuate antimicrobial resistance that may be associated with augmented prophylaxis. In addition, while TP biopsy may be traditionally performed under general anesthesia using a template grid, it may also be performed freehand under local anesthesia or sedation. Avoiding prophylactic antibiotics and general anesthesia as well as reducing infections/hospitalizations for TP biopsy scaled nationally will likely result in significant healthcare savings. TP biopsy with combined systematic and MRI-targeted cores, offers several advantages over conventional TR biopsy. TP biopsy under local anesthesia and without periprocedural antibiotic is emerging as a promising method for prostate cancer diagnosis and surveillance.